✦ LIBER ✦

1206 NONCLINICAL AND CROSS-GENOTYPIC PROFILES OF GS-9669, A NOVEL HCV NS5B NON-NUCLEOSIDE THUMB SITE II INHIBITOR

✍ Scribed by Fenaux, M.; Tian, Y.; Matles, M.; Mabery, E.; Zhang, Jingyu; Eng, S.; Murray, B.; Mwangi, J.; Lazerwith, S.; Lew, W.; Canales, E.; Liu, Q.; Byun, D.; Doerffler, E.; Ye, H.; Clarke, M.; Mertzman, M.; Morganelli, P.; Zhang, Jennifer; Leavitt, S.; Appleby, T.; Hashash, A.; Bidgood, A.; Krawczyk, S.; Watkins, W.

Book ID: 122422484
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 41 KB
Volume: 54
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(11)61208-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of Nucleotide Polymerase Inhibi

Efficacy of Nucleotide Polymerase Inhibitor Sofosbuvir Plus the NS5A Inhibitor Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669 Against HCV Genotype 1 Infection

✍ Gane, Edward J.; Stedman, Catherine A.; Hyland, Robert H.; Ding, Xiao; Svarovska 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 585 KB

1193 RESISTANCE ANALYSES USING DEEP AND

1193 RESISTANCE ANALYSES USING DEEP AND POPULATION SEQUENCING AFTER 3 DAY MONOTHERAPY WITH GS-9669, A NOVEL NON-NUCLEOSIDE NS5B INHIBITOR IN GENOTYPE 1 HCV PATIENTS

✍ Dvory-Sobol, H.; Svarovskaia, E.S.; Gontcharova, V.; Rossi, S.; Lawitz, E.J.; Mi 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 53 KB

1189 GS-9669, A NOVEL NS5B NON-NUCLEOTID

1189 GS-9669, A NOVEL NS5B NON-NUCLEOTIDE SITE II INHIBITOR, DEMONSTRATES POTENT ANTIVIRAL ACTIVITY, FAVORABLE SAFETY PROFILE AND POTENTIAL FOR ONCE-DAILY DOSING

✍ Lawitz, E.; Hazan, L.; Gruener, D.; Hack, H.; Backonja, M.; Hill, J.; German, P. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 60 KB